RTOG Foundation Study 3502
Study Date: January 3, 2020 | Status: Closed to Accrual
POSTILV
A Randomized Phase II Trial In Patients With Operable Stage I Non-Small Cell Lung Cancer: Radical Resection Versus Ablative Stereotactic Radiotherapy
Principal Investigators
China: Jinming Yu, MD, PhD
U.S.: Feng-Ming (Spring) Kong, MD, PhD
Primary Objective
To determine whether SBRT provides local-regional tumor control that is not more than 15% lower than RODS.
Patient Population
Patients must have histologically proven CT and PET-CT confirmed Stage I, T1N0M0 non-small cell lung cancer.
Participating Sites
| Institution Name | City | State/Country |
|---|---|---|
| Chinese Academy of Medical Sciences | Beijing | China |
| Shandong Cancer Hospital | Jinan | Shandong, China |
| Shanghai Cancer Center/Fudan University | Shanghai | China |
| Zhejiang Cancer Hospital | Hangzhou | Zhejiang, China |